Current Treatment of Isolated Locoregional Breast Cancer Recurrences.

Abstract

Patients with isolated locoregional breast cancer recurrences should be treated with curative intent. Mastectomy is regarded as the standard of care for patients with ipsilateral breast tumor recurrence. In a selected group of patients, partial breast irradiation after second breast-conserving surgery is a viable alternative to mastectomy. If a second breast conservation is performed, additional irradiation should be mandatory, especially in patients who had not been irradiated previously. In case of re-irradiation, the largest experience exists for multi-catheter brachytherapy. Prospective clinical trials are needed to clearly define selection criteria, long-term local control, and toxicity. In patients with resectable locoregional breast cancer recurrences after mastectomy, multi-modal therapy comprising complete resection, radiation therapy in previously unirradiated patients, and systemic therapy results in 5-year disease-free and overall survival rates of 69% and 88%, respectively. In radiation-naive patients with unresectable, isolated locoregional recurrences, radiation therapy is mandatory. In selected patients with previous irradiations and unresectable locoregional recurrences, a second irradiation as part of an individual treatment concept can be applied. The increased risk of severe toxicity should always be weighed up against the potential clinical benefit. A combination therapy with hyperthermia can further improve the treatment results.

• Authors: Wolfgang Harms, Andreas Geretschläger, Corinne Cescato, Martin Buess, Dieter Köberle, Branca Asadpour
• Journal: Breast care (Basel, Switzerland) (Breast Care (Basel)) Vol. 10 Issue 4 Pg. 265-71 (Aug 2015) ISSN: 1661-3791 [Print] Switzerland
• PMID: 26600763 (Publication Type: Journal Article, Review)